Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
24S-hydroxycholesterol in plasma: A marker of cholesterol turnover in neurodegenerative diseases.
Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica.
Vitamin D as a clinical biomarker in multiple sclerosis.
Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10.
Obtaining from Grape Pomace an Enzymatic Extract with Anti-inflammatory Properties.
EBNA2 Binds to Genomic Intervals Associated with Multiple Sclerosis and Overlaps with Vitamin D Receptor Occupancy.
Levels of plasma sulfatides C18:0 and C24:1 correlate with disease status in Relapsing-Remitting Multiple Sclerosis.
Optic nerve head component analysis enters the clinic: Will multifocal ERG be the next OCT?
Injury to a specific neural pathway detected by Ultra-high-field MRI.
Caregiver burden, quality of life and walking ability in different disability levels of multiple sclerosis.
Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity.
Management of multiple sclerosis in adolescents - current treatment options and related adherence issues.
PET imaging of glucose metabolism, neuroinflammation and demyelination in the lysolecithin rat model for multiple sclerosis.
PET imaging in multiple sclerosis.
Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases.
Macrophages derived from infiltrating monocytes mediate autoimmune myelin destruction.
CD226 Gly307Ser Association With Neuromyelitis Optica in Southern Han Chinese.
Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance.
Correlations between serum uric Acid level and disease activity, intrathecal inflammation reactivity in patients with multiple sclerosis.
The role of IL-2 in the activation and expansion of regulatory T-cells and the development of experimental autoimmune encephalomyelitis.
Temporal aspects of visual perception in demyelinative diseases.
Neurons and T cells: Understanding this interaction for inflammatory neurological diseases.
IL-17A is implicated in lipopolysaccharide-induced neuroinflammation and cognitive impairment in aged rats via microglial activation.
Association of sex hormones and glucose metabolism with the severity of multiple sclerosis.
Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
345
346
347
348
349
350
351
352
353
…
next ›
last »